Aprotinin decreases exposure to allogeneic blood during primary unilateral total hip replacement.
about
Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusionTransfusion practices for elective orthopedic surgery.What is the evidence for using hemostatic agents in surgery?Aprotinin and major orthopedic surgeryAprotinin and classic wound drainage are unnecessary in total hip replacement - a prospective randomized trial.Low risk of thromboembolic complications with tranexamic acid after primary total hip and knee arthroplasty.Preliminary results suggest tranexamic acid is safe and effective in arthroplasty patients with severe comorbidities
P2860
Q24235627-D1282A5F-1942-4B8F-B130-A32CCE2CE963Q34010965-BAE120F6-1A48-48BA-BA9C-4E335AF24EFBQ35767672-5CBABAE4-8F4B-46AE-9115-0FD864EAE11CQ35827396-73AA611B-64DB-41A4-B58B-CB6B7FE9D8C3Q35958939-29C18816-22D8-4344-9495-F3740F51702CQ36484729-ABA605F1-0508-42B3-A8E7-9940024F5DEBQ37468834-FC65B0DF-FD4D-48F6-8384-BD25191F0D03
P2860
Aprotinin decreases exposure to allogeneic blood during primary unilateral total hip replacement.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
2000年论文
@zh
2000年论文
@zh-cn
name
Aprotinin decreases exposure t ...... lateral total hip replacement.
@en
type
label
Aprotinin decreases exposure t ...... lateral total hip replacement.
@en
prefLabel
Aprotinin decreases exposure t ...... lateral total hip replacement.
@en
P2093
P1476
Aprotinin decreases exposure t ...... ilateral total hip replacement
@en
P2093
B B Ruzicka
J M Murkin
J McCutchen
M E Comunale
P304
P356
10.2106/00004623-200005000-00008
P407
P577
2000-05-01T00:00:00Z